期刊文献+

p53蛋白与肝细胞癌临床病理特征及预后的关系 被引量:1

The Expression of p53 Protein and its Relationship with Clinical Pathological Feature and Prognosis in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的探讨p53蛋白表达与肝细胞癌的临床病理特征及预后的关系,为术后综合治疗及判断预后提供依据。方法采用免疫组织化学方法检测88例肝细胞癌组织中p53蛋白的表达,比较阳性患者和阴性患者的临床病理因素和术后累积复发率、术后累积生存率的差异。结果p53蛋白表达阳性组12、3、累积生存率分别为75.0%、54.4%2、4.2%,阴性组相应的分别为84.3%、77.8%、56.1%。与阴性组相比,p53蛋白阳性组有较高的术前AFP浓度(P=0.005)、有较大的肿瘤最大直径(P=0.042)、肿瘤包膜不完整或无包膜者多见(P=0.023)。结论p53蛋白是评价肝细胞癌恶性程度及预后的一个有价值的生物学指标。 Objective To investigate the expression of p53 protein in hepatocellular carcinoma (HCC) and its relationship with clinical pathological feature and prognosis of HCC and to provide the reference for the postoperative comprehensive therapy and the judgment of prognosis. Methods The expression of p53 protein in 88 specimens of HCC was detected by immunohistochemical S-P method. It was divided into two groups: the group of p53 protein positive and the group of p53 portein negative. The clinical pathological factors, postoperative cu- mulative relapse frequencies and postoperative cumulative survival rates were compared between 2 groups. Results The postoperative cumulative survival rate of 1,2,3 years in the group of p53 protein positive was75.0% ,54.4%,24.2%, respectively. In the group of p53 protein negative it was 84.3 %, 77.8 %, 56.1%, respectively. The difference of postoperative cumulative survival rate between 2 groups had statistically significance (x^2 = 4.032, P = 0.045). Compared with the group of p53 protein negative, the group of p53 protein positive had higher preoperative AFP level (P = 0.005) and larger tumor maximum diameter (P = 0.042). Cases of patients with imcomplete or absent tumor capsular formation in the group of p53 protein positive were more than the group of p53 protein negative (P = 0.023). Conclusion p53 gene can be regarded as a valuable biological indication to evaluate the malignant degree and prognosis of HCC. The expression of p53 protein positive in HCC is closely related to preoperative AFP level, tumor maximum diameter, tumor capsular formation, postoperative recurrence and postoperative prognosis.
出处 《湘南学院学报(医学版)》 2008年第1期10-12,15,共4页 Journal of Xiangnan University(Medical Sciences)
关键词 P53基因 肝细胞癌 临床病理特征 预后 p53 gene Hepatocellular carcinoma Clinical pathological feature Prognosis
  • 相关文献

参考文献4

二级参考文献61

  • 1MENG SEN LI, PING FENG LI, FBI YI YANG, SHI PENG HE, Guo GUANG DU, GANG LI1 Department of Biochemistry and Molecular Biology, 2 Department of Biophysics, Health Science Center, Peking University, Beijing 100083, China.The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells[J].Cell Research,2002,12(2):151-156. 被引量:27
  • 2Shieh YSC, Nguyen C, Vocal MV, Chu HW. Tumor suppressorp 53gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Int J Cancer 1993; 54:558-562. 被引量:1
  • 3Nishida N, Fukuda-Y, Kokuryu H, Toguchida J, YandeU DW,Ikenega M. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 1993; 53:368-372. 被引量:1
  • 4Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350:429-431. 被引量:1
  • 5Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K.Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 1993; 53:2884-2887. 被引量:1
  • 6Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocelllular carcinoma. Cancer Res 1992;52:6358-6364. 被引量:1
  • 7Puisieux A, Ponchel F, Ozturk M. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells. Oncogene 1993; 8:487-490. 被引量:1
  • 8Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 1973-1077. 被引量:1
  • 9Slagle BL. p53 mutations and hepatitis B virus: cofactors in hepatocellular carcinoma. Hepatology 1995; 21:597-599. 被引量:1
  • 10Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW,Ikenega M. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 1993; 53:368-372. 被引量:1

共引文献40

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部